Bill C-393 in the Senate: Amendments to the Patent Act (March 2011)

Bill C-393 passed with a large majority of votes in the House of Commons in Parliament on March 9, 2011 and is now before the Senate of Canada. Bill C-393 would make a number of changes to the sections of the Patent Act that currently constitute Canada’s Access to Medicines Regime (CAMR). The text below lays out in full the sections of the Patent Act that constitute CAMR and tracks onto them the changes that would be made if Bill C-393, in the form passed by the House of Commons, were to become law. This illustrates how the final provisions of CAMR would read as a result of enacting Bill C-393.